Cerebrospinal fluid NCAM levels are modulated by disease-modifying therapies.

Axelsson, Markus; Dubuisson, Nicolas; Novakova, Lenka; Malmeström, Clas; Giovannoni, Gavin; Lycke, Jan; Gnanapavan, Sharmilee

Axelsson, Markus; Dubuisson, Nicolas; Novakova, Lenka; Malmeström, Clas; Giovannoni, Gavin; Lycke, Jan; Gnanapavan, Sharmilee.

Afiliação

Axelsson M; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Dubuisson N; Department of Neuroscience and Trauma, Blizard Institute, Queen Mary University of London, London, UK.
Novakova L; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Malmeström C; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Giovannoni G; Department of Neuroscience and Trauma, Blizard Institute, Queen Mary University of London, London, UK.
Lycke J; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Gnanapavan S; Department of Neuroscience and Trauma, Blizard Institute, Queen Mary University of London, London, UK.

Acta Neurol Scand ; 139(5): 422-427, 2019 May.

Article em En | MEDLINE | ID: mdl-30657162

Assuntos

Biomarcadores/líquido cefalorraquidiano; Antígeno CD56/líquido cefalorraquidiano; Fatores Imunológicos/uso terapêutico; Esclerose Múltipla Recidivante-Remitente/líquido cefalorraquidiano; Esclerose Múltipla Recidivante-Remitente/dietoterapia; Adulto; Ensaio de Imunoadsorção Enzimática; Feminino; Cloridrato de Fingolimode/uso terapêutico; Humanos; Masculino; Pessoa de Meia-Idade; Mitoxantrona/uso terapêutico; Esclerose Múltipla/líquido cefalorraquidiano; Natalizumab/uso terapêutico

Palavras-chave

Cerebrospinal fluid (CSF); Disease-modifying therapies (DMTs); EDSS; Multiple sclerosis (MS); Soluble neural cell adhesion molecule (sNCAM)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores / Antígeno CD56 / Esclerose Múltipla Recidivante-Remitente / Fatores Imunológicos Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google